Peter Sørensen

Senior Scientist, Center for Quantitative Genetics and Genomics, Aarhus University

Peter Sørensen is a Senior Scientist at Center for Quantitative Genetics and Genomics with a background in quantitative genetics. His research focus on developing statistical and genetic models for better understanding and predicting complex traits and diseases. His role is to coordinate the development of statistical modeling approaches part of the BALDER project and providing genetic associations based on integrated analyses of genomic datasets for T2DM and correlated trait.

Mads Fuglsang Kjølby

Associate Professor, Department of Biomedicine, Aarhus University, Clinical Pharmacology and Steno Diabetes Center Aarhus, Aarhus University Hospital

Mads Fuglsang Kjølby is a consultant in Clinical Pharmacology with focus on Precision Medicine in Diabetes. His research is focused on drug target identification and drug development in the field of metabolic diseases. His role is to coordinate the T2DM genomic informed drug target identification approaches in the BALDER project and providing potential T2DM drug targets based on integrated analyses of genomic datasets for T2DM and correlated trait.

Joanna Howson

Senior Director Genetics, Novo Nordisk Research Centre Oxford

Joanna Howson is Senior Director at Novo Nordisk Research Centre Oxford with a background in statistical genetics. Her research harnesses human genetics with other ‘omics to identify future drug targets for cardiometabolic disease, with the aim of bringing the best treatments to patients. Her role is to supervise the statistical model development and T2DM genomic informed drug target identification approaches in the BALDER project.